NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,939 | -70.6% | 117,700 | -29.0% | 0.00% | -100.0% |
| Q2 2023 | $429,080 | -27.2% | 165,668 | +14.6% | 0.00% | -50.0% |
| Q1 2023 | $589,654 | -23.3% | 144,523 | -5.7% | 0.00% | 0.0% |
| Q4 2022 | $769,154 | +89.9% | 153,218 | +394.5% | 0.00% | +100.0% |
| Q3 2022 | $405,000 | -2.4% | 30,983 | -4.3% | 0.00% | 0.0% |
| Q2 2022 | $415,000 | -18.8% | 32,360 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $511,000 | -13.8% | 33,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $593,000 | -15.8% | 33,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $704,000 | +6.5% | 33,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $661,000 | -32.1% | 33,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $974,000 | -4.0% | 33,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,015,000 | +69.2% | 33,500 | -11.1% | 0.00% | +100.0% |
| Q3 2020 | $600,000 | -19.4% | 37,700 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $744,000 | +60.0% | 37,700 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $465,000 | +148.7% | 37,700 | +273.3% | 0.00% | – |
| Q4 2019 | $187,000 | +33.6% | 10,100 | 0.0% | 0.00% | – |
| Q3 2019 | $140,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |